Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab

Ähnliche Einträge

• Pure red cell aplasia after ABO incompatible allogeneic stem cell transplantation treated with therapeutic plasma exchange: A case report
  von: Abhijit Baheti, et al.
  Veröffentlicht: (2025)
• Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation
  von: Moazzam Shahzad, et al.
  Veröffentlicht: (2024)
• High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality
  von: Zachary M. Avigan, et al.
  Veröffentlicht: (2024)
• Anti‐donor antibody neutralization by donor type red cell challenge: A novel therapeutic strategy in refractory post‐transplant pure red cell aplasia
  von: Mayank Soni, et al.
  Veröffentlicht: (2024)
• Method comparison between hematopoietic progenitor cell and CD34+ cell counts in hematopoietic stem cell collection
  von: Thibault Lavalleye, et al.
  Veröffentlicht: (2024)